NCT00631124View on ClinicalTrials.gov

A Study to Evaluate Inhibition of Ovulation of Two Oral Estrogen/Progestogen Regimens in Healthy, Young Females Over a Period of 3 Treatment Cycles

PHASE2CompletedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

October 31, 2008

Study Completion Date

December 31, 2008

Conditions
Contraception
Interventions
DRUG

BAY86-4891 (Estradiol / Drospirenone)

Monophasic regimen containing estrogen and progestin 1 pre-treatment cycle, 3 treatment cycles

DRUG

BAY86-4891 (Estradiol / Drospirenone)

Triphasic regimen containing estrogen and progestin 1 pre-treatment cycle, 3 treatment cycles

Trial Locations (2)

10115

Berlin

13353

Berlin

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY